In 2024, the United States health care sector employed nearly 18 million people, a figure often highlighted by politicians as a testament to the industry’s economic significance and its role in supporting the middle class. However, a closer examination reveals that much of this growth has been in administrative roles rather than clinical positions. Over the past five decades, while the number of physicians has doubled, the number of health care administrators has surged by more than 600 percent. Roles such as billing, prior authorization, coding, and denial management have expanded rapidly, a trend not seen in other wealthy nations that prioritize employing more doctors and nurses over administrators.

This administrative growth contributes to rising costs and inefficiencies without improving patient care. Experts argue that the American health care system excels in medical innovation and complex treatments, driven by institutions like the National Institutes of Health and world-class academic medical centers. Yet, the benefits of these advances are often overshadowed by the burdens of excessive bureaucracy, opaque pricing, and market consolidation that act more as barriers than facilitators of effective care delivery.

Efforts to make care more affordable must balance market-driven and government-led approaches. Proposed measures include enhanced antitrust enforcement, expansion of ambulatory surgery centers, value-based payment models, and maximizing the roles of nurse practitioners and pharmacists. Meanwhile, government actions could involve enforceable price caps, drug price negotiations, standardized insurance regulations, and simplifying administrative processes. Advocates emphasize that reforms should be evaluated on whether they reduce costs without compromising quality, rather than fitting neatly into political ideologies.

Urgency surrounds these reform efforts due to demographic and therapeutic shifts. With the population aged 65 and older already exceeding 60 million and expected to approach 80 million by 2040, demand for chronic disease management and long-term care is rising. Simultaneously, breakthroughs in cell and gene therapies promise potentially curative treatments but often come with multi-million-dollar price tags. Without addressing existing inefficiencies—such as administrative bloat and inflated prices—the system risks becoming financially unsustainable.

Delays in implementing reform come with tangible costs. Each year of inaction allows further consolidation in health care markets, securing contracts at high rates and entrenching administrative complexity. This contributes to rising premiums and out-of-pocket expenses, placing pressure on both insured and uninsured populations. On the governmental side, expanding health care expenditures limit funding available for education, infrastructure, and other long-term public investments.

Though federal legislation remains critical for issues like drug pricing and Medicare reform, states hold significant powers that could drive change independently. Initiatives such as repealing certificate-of-need laws, modernizing scope-of-practice regulations, enforcing price transparency, and establishing affordability boards have yielded results in places like Indiana, where hospital price caps tied to Medicare rates have been introduced.

Despite clear evidence and numerous proposals for reducing health care costs, entrenched interests benefiting from the current system have slowed progress. The challenge now lies in whether policymakers across all levels of government are prepared to act decisively to curtail rising costs and improve affordability for Americans nationwide.